Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care (Optimierung Der Pharmakologischen Überleitung Von Palliativpatient:Innen Von stationär Nach Ambulant)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- University Hospital Muenster
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- (I) Drug-related problems
- Status
- Recruiting
- Last Updated
- 10 months ago
Overview
Brief Summary
The transition of palliative care patients from inpatient to outpatient care is aimed to be improved through structured pharmaceutical discharge management by a trained pharmacist. This data will be compared with retrospective cases.
Detailed Description
As part of a prospective observational study with a retrospective comparison group, a pharmacist should, on request, check the discharge medication planned by the primary care physicians before discharge and discuss it with the various colleagues providing (follow-up) care. In addition, the availability in the outpatient "medicine cabinet" and the possibility of prescribing by the responsible GPs (by telephone) should be checked in advance. In addition, longitudinal focus groups with relevant stakeholders are to be conducted to collect quantitative data as well as qualitative data on the views of those providing and receiving treatment. There will be cooperation with the Specialized Outpatient Palliative Care Service Muenster to ensure sufficient case numbers and a low rate of missing values through partial use of the standard care data from the "Information System Palliative Care" (ISPC) program they use.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All individual indications for general and specialised palliative care as part of routine clinical practice (e.g.):
- •advanced, malignant tumour disease
- •advanced, chronic obstructive pulmonary disease
- •Patients with advanced disease and limited life expectancy (approx. 12 months) Further care in the SOPC Muenster (prospective data) Sufficient understanding of the German language to be able to understand the information and consent form
Exclusion Criteria
- •Impossibility of understanding the information and declaration of consent.
Outcomes
Primary Outcomes
(I) Drug-related problems
Time Frame: 12 months
(I) Number of drug-related problems at the time of discharge according to PCNE (comparison of prospective, actually proposed changes vs. hypothetical number and type of problems at the time of discharge in the retrospective comparison cohort)
(II) Drug-related problems
Time Frame: 12 months
(II) Type of drug-related problems at the time of discharge according to PCNE (comparison of prospective, actually proposed changes vs. hypothetical number and type of problems at the time of discharge in the retrospective comparison cohort)
Secondary Outcomes
- Number of contacts(12 months)
- Number of readmissions / visits(12 months)
- Symptom burden(12 months)
- (I) Medication changes(12 months)
- Adoption rate(12 months)
- (I) GP contact(12 months)
- (I) SOPC contact(12 months)
- Focus groups(12 months)
- (I) Post-discharge medication changes(12 months)
- (I) Further parameters(12 months)
- (II) GP contact(12 months)
- (II) Post-discharge medication changes(12 months)
- (II) Further parameters(12 months)
- (II) Medication changes(12 months)
- (II) SOPC contact(12 months)